DEV SITE
Tara Carlisle, MD
Behavioral Neurology
Locations
Practice Locations
CU Memory Disorders Clinic - Central Park
720-848-2080
Provider Expertise
Care Philosophy
I strive to provide the best care for my patients. I believe in treating the person as a whole, taking every aspect of brain health into consideration during diagnosis and treatment.
Specialties
- Neurology ( 2020 )
- Behavioral Neurology ( 2022 )
Conditions & Treatments
-
Brain and Nervous System
Alzheimer's Disease, CADASIL Syndrome, Cognitive Changes, Dementia with Lewy Bodies, Frontotemporal Dementia, Hydrocephalus, Lewy Body Dementia, Memory disorders, Memory Loss, Mild Cognitive Impairment, Parkinson's Disease Dementia, Posterior Cortical Atrophy, Vascular Dementia
Education & Training
Medical Schools
MD, University of Colorado Denver School of Medicine (2007)
Undergraduate Schools
BA/BS, University of Colorado - Boulder (CO) (2002)
Graduate Schools
PhD, University of Colorado Health Sciences Center (2007)
Internships
University of Colorado (University Hospital) Program (2016)
Residency Program
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School Program (2017)
Fellowships
University of Colorado (University Hospital) Program (2020)
Professional Memberships
Alpha Omega Alpha, Member
American Academy of Neurology, Member
American Neuropsychiatric Association, Member
Research & Grants
Grants
Pilot Grant: Development and validation of a clinical predictor tool for cognitive decline in Parkinson’s disease (2020)
Intradepartmental Grant: Refinement of a clinical predictor tool using modifiable cognitive decline risk factors in Parkinson’s disease (2022)
Safety of Lecanemab in Atypical Alzheimer’s Disease (2024)
Research Interests for Patients
My research explores personalized risk assessment, lifestyle recommendations, and potential disease-altering approaches for those most likely to benefit. I have a passion for preventing dementia. I have an interest in cognitive decline in Parkinson's disease focusing on modifiable and/or treatable risk factors. I am interested in understanding the profound sex differences in Alzheimer's disease. I am also interested in the real-world response to anti-amyloid therapies in populations not well-represented in the original clinical trials including atypical presentations of Alzheimer's disease.
information for referring providers
Referral Contact Phone
(720) 848-2080
Clinical Interests for Referring Providers
My clinical interests are cognitive decline suspected to be due to underlying neurodegenerative processes including Alzheimer's disease, Lewy body disorders, and frontotemporal lobar dementias. I also see patients with cognitive decline suspected due to structural brain changes, including white matter disease, vascular dementia, cerebral amyloid angiopathy, disorders of cerebral spinal fluid, and others.